Hesperetin alleviated glucocorticoid-induced inhibition of osteogenic differentiation of BMSCs through regulating the ERK signaling pathway
In conclusion, our study demonstrated that hesperetin alleviated glucocorticoid-induced inhibition of osteogenic differentiation through ERK signal pathway in BMSCs. It may be a potential therapeutic agent for protecting against glucocorticoid-induced osteoporosis.
Source: Medical Molecular Morphology - Category: Molecular Biology Source Type: research
More News: Dexamethasone | Molecular Biology | Orthopaedics | Osteoporosis | Stem Cell Therapy | Stem Cells | Study